Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: The first 100 patients

American Journal of Gastroenterology

Volumn 96, Issue 3, 2001, Pages 722-729

  Ricart, Elena ^a   Panaccione, Remo ^a   Loftus, Edward V ^a   Tremaine, William J ^a   Sandborn, William J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; STEROID;

ABSCESS; ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDIASIS; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HERPES ZOSTER; HUMAN; INFLAMMATORY DISEASE; INFUSION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; RECTUM FISTULA; STEROID THERAPY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; CROHN DISEASE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL FISTULA; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0035068351     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02405-9     Document Type: Article

References (11)

1. Management of Crohn's disease in adults
2. National Cooperative Crohn's Disease Study. Results of drug treatment
3. Complications of corticosteroid therapy
4. A review of immune modifier therapy for inflammatory bowel disease: Azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate
5. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
6. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease
7. Infliximab for the treatment of fistulas in patients with Crohn's disease
8. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
9. Successful management of Crohn's disease of the ileoanal pouch with infliximab
10. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis